Skip to main content
. 2016 Jun 19;2016:4897501. doi: 10.1155/2016/4897501

Figure 2.

Figure 2

Antiretroviral drug resistance testing and therapy changes in women with perinatal and nonperinatal HIV infection. The proportion of women with a genotype collected and ARV resistance accounts for the number of participants eligible to have a genotype evaluated (HIV RNA viral load > 1,000 copies/mL). ARV resistance and multidrug resistance rates were significantly different between groups.